Trident Lifeline promoter Rupaben Chetanbhai Jariwala has disclosed the sale of equity shares through open market transactions, as per regulatory filings submitted to BSE Limited. The transactions were conducted in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Share Sale Transactions

The promoter executed two separate share sale transactions during the period. The disclosure documents reveal the following transaction details:

Shareholding Pattern Changes

The transactions resulted in a reduction of Rupaben Jariwala's shareholding in Trident Lifeline Limited. Her holding pattern changed as follows:

Company Capital Structure

Trident Lifeline Limited's capital structure remained unchanged throughout these transactions. The company maintains:

• Equity Share Capital: Rs. 11,93,30,000
• Number of Equity Shares: 1,19,33,000 shares of Rs. 10 each
• Total Diluted Share Capital: Rs. 12,49,34,000 (1,24,93,400 equity shares of Rs. 10 each)

Regulatory Compliance

The disclosures were made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Rupaben Chetanbhai Jariwala, identified as a promoter category shareholder, submitted the required documentation to both BSE Limited and Trident Lifeline Limited. The company's shares are listed on BSE Limited under scrip code 543616.

Trident Lifeline Limited conducted a separate meeting of Independent Directors on March 28, 2026, fulfilling its regulatory obligations under SEBI guidelines and the Companies Act. The meeting was held in accordance with established governance protocols to ensure effective board oversight and performance evaluation.

Regulatory Framework and Compliance

The meeting was conducted pursuant to Regulation 25(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with Schedule IV of Companies Act, 2013. This regulatory framework mandates separate meetings of Independent Directors to maintain corporate governance standards and ensure independent oversight of company operations.

Meeting Agenda and Key Discussions

The Independent Directors addressed three critical areas of governance during their deliberations:

Meeting Duration and Logistics

The Independent Directors' meeting was efficiently conducted within a focused timeframe:

Governance Objectives

The meeting addressed fundamental governance responsibilities including the review of Non-Independent Directors' performance and overall Board effectiveness. The Independent Directors also evaluated the Chairman's performance, incorporating perspectives from both executive and non-executive directors to ensure comprehensive assessment.

Additionally, the directors assessed the adequacy of information flow between company management and the Board, ensuring that directors receive necessary information in appropriate quality, quantity, and timing to perform their duties effectively.

Corporate Communication

The outcome was formally communicated to BSE Limited under the company's stock ID TLL and scrip code 543616. Company Secretary and Compliance Officer Nikita Sharma signed the disclosure document, maintaining transparency with stakeholders and regulatory compliance.